Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance. Issue 12 (4th November 2017)

• Record Type: Journal Article
• Authors: Carraro, Amedeo; Trevellin, Elisabetta; Fassan, Matteo; Kotsafti, Andromachi; Lunardi, Francesca; Porzionato, Andrea; Dall'Olmo, Luigi; Cagol, Matteo; Alfieri, Rita; Macchi, Veronica; Tedeschi, Umberto; Calabrese, Fiorella; Rugge, Massimo; Castoro, Carlo; Vettor, Roberto; Scarpa, Marco
• Is Part Of: Cancer science. Volume 108:Issue 12(2017)
• Page Start: 2393
• Page End: 2404
• Publication Date: 2017-11-04
• Subjects: adipose tissue -- esophageal adenocarcinoma -- neoadjuvant therapy -- peritumoral microenvironment -- stem cell; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.13415
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract : Peritumoral microenvironment affects cancer development and chemoresistance, and visceral adipose tissue may play a critical role. We aimed to identify depot‐specific adipose characteristics associated with carcinogenesis and resistance to neoadjuvant therapy in esophageal adenocarcinoma (EAC). We analyzed: (i) the peritumoral adipose tissue of rats following the induction of esophageal carcinogenesis; (ii) the peritumoral and distal (omental) adipose tissue of patients affected by EAC; (iii) adipose‐derived stem cells (ADSC) isolated from healthy patients and treated with conditioned medium (CM), collected from tumoral and adipose tissue of patients with EAC. In peritumoral adipose tissue of rats, CD34, CD31 and vascular endothelial growth factor (VEGF) expression increased progressively during EAC development. In patients with EAC, expression of CD34, CD45, CD90 and nucleostemin (NSTM) was higher in peritumoral than in distal adipose tissue and decreased in the presence of neoadjuvant therapy. Moreover, expression of NSTM, octamer‐binding transcription factor 4 (OCT‐4) and VEGF was higher in peritumoral (but not in distal) adipose tissue of chemoresistant patients. In ADSC, treatment with peritumoral adipose tissue CM increased the adipogenic potential and the expression of CD34, CD90, NSTM and OCT‐4. These effects were similar to those induced by cancer‐derived CM, but were not observed in ADSC treated with distal adipose tissue CM and were partially reduced by a leptin antagonist. Last, ADSC treated with peritumoral CM of chemoresistant patients displayed increased expression of NSTM, OCT‐4, leptin, leptin receptor, alpha‐smooth muscle actin (α‐SMA), CD34 and VEGF. These results suggest that peritumoral adipose tissue may promote, by paracrine signaling, the expression of depot‐specific factors associated with therapeutic resistance. Abstract : This study shows for the first time that the adipose tissue adjacent to esophageal adenocarcinoma of chemoresistant patients is characterized by an increased expression ( in vivo ) and ability to induction ( in vitro ) of genes involved in stemness and neoangiogenesis. These characteristics were not observed in their farthest adipose depot or in tumor‐adjacent adipose tissue of patients with good response to therapy, suggesting a specific role of peritumoral adipose tissue in chemoresistance.